Related Experiment Video
Updated: Aug 9, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Advances in antiretroviral therapy
Magdalena E Sobieszczyk1, Joyce Jones, Timothy Wilkin
1Columbia University Medical Center, New York, NY, USA.
Summary
The 25th anniversary of AIDS and 10th of antiretroviral therapy (ART) were marked by significant advancements. New agents, treatment strategies, and global ART rollout programs show promising progress in HIV/AIDS management.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- The year 2006 marks the 25th anniversary of the Acquired Immunodeficiency Syndrome (AIDS) epidemic.
- It also signifies the 10th anniversary of the potent antiretroviral therapy (ART) era in HIV/AIDS management.
- The Conference on Retroviruses and Opportunistic Infections (CROI) serves as a premier scientific forum for disseminating cutting-edge research.
Framework:
- The 2006 CROI highlighted key developments in antiretroviral therapeutics.
- Presentations focused on novel antiretroviral agents and innovative therapeutic strategies.
- Discussions included critical analyses of treatment interruption studies and viral resistance patterns.
Implementation:
- Encouraging results from antiretroviral rollout programs in developing nations were presented.
- These initiatives demonstrate the expanding global access to life-saving HIV/AIDS treatments.
- The successful implementation of ART in resource-limited settings is a major focus.
Implications:
- The convergence of research and global health initiatives heralds a new era in HIV/AIDS treatment.
- Continued investigation into viral resistance and novel therapies is crucial.
- The findings underscore the transformative impact of ART on clinical outcomes and public health.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...